Sonic Healthcare Ltd SHL

Morningstar Rating

Company Report

Sonic Healthcare Reports In-Line Fiscal 2026, but Near-Term Outlook Cloudy

Sonic Healthcare provides laboratory medicine/pathology and diagnostic imaging radiology. It is the third-largest private provider of laboratory medicine globally, behind Quest Diagnostics and Labcorp. Strategy focuses on being a low-cost provider and gaining cost advantage over competitors through scale. This has mostly been pursued through acquisitions, buying smaller operators to expand its market share in geographies where it operates. The firm emphasizes medical leadership, recognizing referring doctors as the primary customer, focusing on improving their experience and efficiency.

Price vs Fair Value

SHL is trading within a range we consider fairly valued.
Price
A$18.46
Fair Value
FG
Uncertainty
LOCK|?TGC
1-Star Price
LOCK|.@t
5-Star Price
LOCK|.zF
Economic Moat
LOCK|$@fM
Capital Allocation
LOCK|XZJW!&

Bulls Say, Bears Say

Bulls

The business is defensive, providing an essential service, not tied to economic cycles.

Bears

Earnings are tied to government policy and funding, and changes in policy to government rebates for laboratory medicine and imaging.

Trading Information

Previous Close Price
—
Day Range
—–—
52-Week Range
—–—
Bid/Ask
— / —
Shares Outstanding
494.24M
Market Cap
—
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
14.22
Price/Sales
0.84
Dividend Yield (Trailing)
5.85%
Dividend Yield (Forward)
5.85%
Dividend Payment Schedule
Mar, Sep
Total Yield
5.85%

Company Profile

Sonic Healthcare is an Australia-based global laboratory medicine/pathology provider. It has global operations and has the largest pathology market share in its home market of Australia, and is also the largest in Germany, Switzerland and the UK. It also provides laboratory medicine services in New Zealand, Belgium and Poland. In addition, Sonic provides diagnostic imaging radiology in Australia, where it is the second-largest operator. Finally, the group is Australia’s biggest medical center operator, providing primary care medical services under the Independent Practitioner Network brand.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Value
Total Number of Employees
41,000

Competitors

Valuation

Metric
SHL
DGX
LH
Price/Earnings (Normalized)
14.2221.7217.42
Price/Book Value
1.093.382.86
Price/Sales
0.842.251.76
Price/Cash Flow
6.5013.4010.88
Price/Earnings
SHL
DGX
LH

Financial Strength

Metric
SHL
DGX
LH
Quick Ratio
0.841.281.25
Current Ratio
0.991.591.80
Interest Coverage
4.986.176.43
Quick Ratio
SHL
DGX
LH

Profitability

Metric
SHL
DGX
LH
Return on Assets (Normalized)
3.74%7.32%6.57%
Return on Equity (Normalized)
7.39%16.42%14.08%
Return on Invested Capital (Normalized)
5.35%10.01%9.11%
Return on Assets
SHL
DGX
LH

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|&$&z&B$sLOCK|%p%$241B
Danaher Corp
DHR
LOCK|Kxw^#W!LOCK|Yr$149B
Agilent Technologies Inc
A
LOCK|cMVcZ?^$LOCK|cGg$47B
IQVIA Holdings Inc
IQV
LOCK|vyYHyZLOCK|#Bhhs$43B
Waters Corp
WAT
LOCK|c@&#ZnLOCK|vH$42B
IDEXX Laboratories Inc
IDXX
LOCK|wLm%>?>LOCK|RH&$41B
Illumina Inc
ILMN
LOCK|H?fB@?LOCK|$@YB>$40B
Mettler-Toledo International Inc
MTD
LOCK|c%L$$yMLOCK|#CbT<$30B
Quest Diagnostics Inc
DGX
LOCK|^j<QlQWLOCK|Y!?%$26B
Labcorp Holdings Inc
LH
LOCK|<r&cFLh>LOCK|JMTpz$25B

Sponsor Center